Combined pituitary hormone deficiency: Current and future status

Journal of Endocrinological Investigation

Volumn 38, Issue 1, 2015, Pages 1-12

  Castinetti, F ^a,b,c   Reynaud, R ^a,b,c   Quentien, M H ^a,b,c   Jullien, N ^a   Marquant, E ^a,b,c   Rochette, C ^a,b,c   Herman, J P ^a   Saveanu, A ^a,b,c,d   Barlier, A ^a,b,c,d   Enjalbert, A ^a,c,d   Brue, T ^a,b,c  

^a University of Mediterranée   (France)

^b TIMONE HOSPITAL   (France)

^c Service d'endocr et Centre de reference des maladies rares d'origine hypophysaire   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Corticotroph deficiency; Gonadotroph deficiency; Hypothalamus; Pituitary development; Somatotroph deficiency; Thyrotroph deficiency; Transcription factor

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; HYPOPHYSIS HORMONE; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ARNT2; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR LHX4; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR PROP1; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ACTH SECRETING CELL; COMBINED PITUITARY HORMONE DEFICIENCY; CONGENITAL DISORDER; DIFFERENTIAL DIAGNOSIS; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HOLOPROSENCEPHALY; HUMAN; HYPOPHYSIS TUMOR; HYPOPITUITARISM; MENTAL DEFICIENCY; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PITUITARY STALK INTERRUPTION SYNDROME; PRENATAL DIAGNOSIS; PROK2 GENE; PROKR2 GENE; PROTEIN EXPRESSION; REVIEW; RISK REDUCTION; SEPTOOPTIC DYSPLASIA; ANIMAL; FORECASTING; GENETICS; GROWTH, DEVELOPMENT AND AGING; HYPOPHYSIS; MUTATION; SECRETION (PROCESS);

ANIMALS; FORECASTING; HUMANS; HYPOPITUITARISM; MUTATION; PHENOTYPE; PITUITARY GLAND; PITUITARY HORMONES;

EID: 84923868222     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/s40618-014-0141-2     Document Type: Review

References (126)

1. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT (2009) Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30(7):790-829. doi:10.1210/er. 2009-0008
2. Castinetti F, Reynaud R, Saveanu A, Quentien MH, Albarel F, Barlier A, Enjalbert A, Brue T (2008) Clinical and genetic aspects of combined pituitary hormone deficiencies. Ann Endocrinol 69(1):7-17. doi:10.1016/j.ando.2008.01.001
3. Schlosser G (2006) Induction and specification of cranial placodes. Dev biol 294(2):303-351. doi:10.1016/j.ydbio.2006.03.009
4. Rizzoti K, Lovell-Badge R (2005) Early development of the pituitary gland: induction and shaping of Rathke's pouch. Rev endocr metab disord 6(3):161-172. doi:10.1007/s11154-005-3047-7
5. Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson IC (2008) SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci USA 105(8):2907-2912. doi:10.1073/pnas.0707886105
6. Gleiberman AS, Michurina T, Encinas JM, Roig JL, Krasnov P, Balordi F, Fishell G, Rosenfeld MG, Enikolopov G (2008) Genetic approaches identify adult pituitary stem cells. Proc Natl Acad Sci USA 105(17):6332-6337. doi:10.1073/pnas.0801644105
7. Garcia-Lavandeira M, Quereda V, Flores I, Saez C, Diaz- Rodriguez E, Japon MA, Ryan AK, Blasco MA, Dieguez C, Malumbres M, Alvarez CV (2009) A GRFa2/Prop1/stem (GPS) cell niche in the pituitary. PLoS ONE 4(3):e4815. doi:10.1371/journal.pone.0004815
8. Gleiberman AS, Fedtsova NG, Rosenfeld MG (1999) Tissue interactions in the induction of anterior pituitary: role of the ventral diencephalon, mesenchyme, and notochord. Dev Biol 213(2):340-353
9. Japon MA, Rubinstein M, Low MJ (1994) In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 42(8):1117-1125
10. Lamolet B, Pulichino AM, Lamonerie T, Gauthier Y, Brue T, Enjalbert A, Drouin J (2001) A pituitary cell-restricted T box factor, Tpit, activates POMC transcription in cooperation with Pitx homeoproteins. Cell 104(6):849-859
11. Webb EA, AlMutair A, Kelberman D, Bacchelli C, Chanudet E, Lescai F, Andoniadou CL, Banyan A, Alsawaid A, Alrifai MT, Alahmesh MA, Balwi M, Mousavy-Gharavy SN, Lukovic B, Burke D, McCabe MJ, Kasia T, Kleta R, Stupka E, Beales PL, Thompson DA, Chong WK, Alkuraya FS, Martinez-Barbera JP, Sowden JC, Dattani MT (2013) ARNT2 mutation causes hypopituitarism, post-natal microcephaly, visual and renal anomalies. Brain 136(Pt 10):3096-3105. doi:10.1093/brain/awt218
12. Di Iorgi N, Allegri AE, Napoli F, Bertelli E, Olivieri I, Rossi A, Maghnie M (2012) The use of neuroimaging for assessing disorders of pituitary development. Clin Endocrinol 76(2):161-176. doi:10.1111/j.1365-2265.2011.04238.x
13. Kelberman D, Dattani MT (2007) Genetics of septo-optic dysplasia. Pituitary 10(4):393-407. doi:10.1007/s11102-007-0055-5
14. Raivio T, Avbelj M, McCabe MJ, Romero CJ, Dwyer AA, Tommiska J, Sykiotis GP, Gregory LC, Diaczok D, Tziaferi V, Elting MW, Padidela R, Plummer L, Martin C, Feng B, Zhang C, Zhou QY, Chen H, Mohammadi M, Quinton R, Sidis Y, Radovick S, Dattani MT, Pitteloud N (2012) Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia. J Clin endocrinol metab 97(4):E694-E699. doi:10.1210/jc.2011-2938
15. Reynaud R, Jayakody SA, Monnier C, Saveanu A, Bouligand J, Guedj AM, Simonin G, Lecomte P, Barlier A, Rondard P, Martinez-Barbera JP, Guiochon-Mantel A, Brue T (2012) PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption. J clin endocrinol metab 97(6):E1068-E1073. doi:10.1210/jc.2011-3056
16. McCabe MJ, Gaston-Massuet C, Gregory LC, Alatzoglou KS, Tziaferi V, Sbai O, Rondard P, Masumoto KH, Nagano M, Shigeyoshi Y, Pfeifer M, Hulse T, Buchanan CR, Pitteloud N, Martinez-Barbera JP, Dattani MT (2013) Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia. J clin endocrinol metab 98(3):E547-E557. doi:10.1210/jc.2012-3067
17. Dubourg C, Bendavid C, Pasquier L, Henry C, Odent S, David V (2007) Holoprosencephaly. Orphanet J Rare Dis 2:8. doi:10. 1186/1750-1172-2-8
18. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 19(2):125-133. doi:10.1038/477
19. Martinez-Barbera JP, Rodriguez TA, Beddington RS (2000) The homeobox gene Hesx1 is required in the anterior neural ectoderm for normal forebrain formation. Dev biol 223(2):422-430. doi:10.1006/dbio.2000.9757
20. Thomas PQ, Johnson BV, Rathjen J, Rathjen PD (1995) Sequence, genomic organization, and expression of the novel homeobox gene Hesx1. J Biol Chem 270(8):3869-3875
21. Webb GC, Thomas PQ, Ford JH, Rathjen PD (1993) Hesx1, a homeobox gene expressed by murine embryonic stem cells, maps to mouse chromosome 14, bands A3-B. Genomics 18(2):464-466. doi:10.1006/geno.1993.1505
22. Gaston-Massuet C, Andoniadou CL, Signore M, Sajedi E, Bird S, Turner JM, Martinez-Barbera JP (2008) Genetic interaction between the homeobox transcription factors HESX1 and SIX3 is required for normal pituitary development. Dev biol 324(2):322-333. doi:10.1016/j.ydbio.2008.08.008
23. Corneli G, Vivenza D, Prodam F, Di Dio G, Vottero A, Rapa A, Bellone S, Bernasconi S, Bona G (2008) Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia. J Endocrinol Invest 31(8):689-693
24. Sobrier ML, Maghnie M, Vie-Luton MP, Secco A, di Iorgi N, Lorini R, Amselem S (2006) Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. J Clin Endocrinol Metab 91(11):4528-4536. doi:10.1210/jc.2006-0426
25. Sobrier ML, Netchine I, Heinrichs C, Thibaud N, Vie- Luton MP, Van Vliet G, Amselem S (2005) Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Hum Mutat 25(5):503. doi:10.1002/ humu.9332
26. Tajima T, Hattorri T, Nakajima T, Okuhara K, Sato K, Abe S, Nakae J, Fujieda K (2003) Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab 88(1):45-50. doi:10.1210/jc.2002-020818
27. Cohen RN, Cohen LE, Botero D, Yu C, Sagar A, Jurkiewicz M, Radovick S (2003) Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 88(10):4832-4839. doi:10.1210/jc.2002-021868
28. Carvalho LR, Woods KS, Mendonca BB, Marcal N, Zamparini AL, Stifani S, Brickman JM, Arnhold IJ, Dattani MT (2003) A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J Clin Investig 112(8):1192-1201. doi:10.1172/JCI18589
29. Mitchell LA, Thomas PQ, Zacharin MR, Scheffer IE (2002) Ectopic posterior pituitary lobe and periventricular heterotopia: cerebral malformations with the same underlying mechanism?AJNR Am J Neuroradiol 23(9):1475-1481
30. Thomas PQ, Dattani MT, Brickman JM, McNay D, Warne G, Zacharin M, Cameron F, Hurst J, Woods K, Dunger D, Stanhope R, Forrest S, Robinson IC, Beddington RS (2001) Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Genet 10(1):39-45
31. Brickman JM, Clements M, Tyrell R, McNay D, Woods K, Warner J, Stewart A, Beddington RS, Dattani M (2001) Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 128(24):5189-5199
32. Kelberman D, Dattani MT (2008) Septo-optic dysplasia-novel insights into the aetiology. Horm Res 69(5):257-265. doi:10.1159/000114856
33. McNay DE, Turton JP, Kelberman D, Woods KS, Brauner R, Papadimitriou A, Keller E, Keller A, Haufs N, Krude H, Shalet SM, Dattani MT (2007) HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab 92(2):691-697. doi:10.1210/jc.2006-1609
34. Reynaud R, Gueydan M, Saveanu A, Vallette-Kasic S, Enjalbert A, Brue T, Barlier A (2006) Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J Clin Endocrinol Metab 91(9):3329-3336. doi:10.1210/jc.2005-2173
35. Webb EA, Dattani MT (2010) Septo-optic dysplasia. Eur J Hum Genet 18(4):393-397. doi:10.1038/ejhg.2009.125
36. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG (1998) Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 12(11):1691-1704
37. Raivio T, Sidis Y, Plummer L, Chen H, Ma J, Mukherjee A, Jacobson-Dickman E, Quinton R, Van Vliet G, Lavoie H, Hughes VA, Dwyer A, Hayes FJ, Xu S, Sparks S, Kaiser UB, Mohammadi M, Pitteloud N (2009) Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 94(11):4380-4390. doi:10.1210/jc.2009-0179
38. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi- Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet-Salmon B, Kottler ML, Richard O, Sanchez-Franco F, Saura R, Young J, Petit C, Hardelin JP (2003) Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33(4):463-465. doi:10.1038/ng1122
39. Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N (2008) Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Investig 118(8):2822-2831. doi:10.1172/JCI34538
40. Martin C, Balasubramanian R, Dwyer AA, Au MG, Sidis Y, Kaiser UB, Seminara SB, Pitteloud N, Zhou QY, Crowley WF Jr (2011) The role of the prokineticin 2 pathway in human reproduction: evidence from the study of human and murine gene mutations. Endocr Rev 32(2):225-246. doi:10.1210/er.2010-0007
41. Larder R, Mellon PL (2009) Otx2 induction of the gonadotro-pin- releasing hormone promoter is modulated by direct interactions with Grg co-repressors. J Biol Chem 284(25):16966-16978. doi:10.1074/jbc.M109.002485
42. Diaczok D, Romero C, Zunich J, Marshall I, Radovick S (2008) A novel dominant negative mutation of OTX2 associated with combined pituitary hormone deficiency. J Clin Endocrinol Metab 93(11):4351-4359. doi:10.1210/jc.2008-1189
43. Dateki S, Fukami M, Sato N, Muroya K, Adachi M, Ogata T (2008) OTX2 mutation in a patient with anophthalmia, short stature, and partial growth hormone deficiency: functional studies using the IRBP, HESX1, and POU1F1 promoters. J Clin Endocrinol Metab 93(10):3697-3702. doi:10.1210/jc.2008-0720
44. Tajima T, Ohtake A, Hoshino M, Amemiya S, Sasaki N, Ishizu K, Fujieda K (2009) OTX2 loss of function mutation causes anophthalmia and combined pituitary hormone deficiency with a small anterior and ectopic posterior pituitary. J Clin Endocrinol Metab 94(1):314-319. doi:10.1210/jc.2008-1219
45. Dateki S, Kosaka K, Hasegawa K, Tanaka H, Azuma N, Yokoya S, Muroya K, Adachi M, Tajima T, Motomura K, Kinoshita E, Moriuchi H, Sato N, Fukami M, Ogata T (2010) Heterozygous orthodenticle homeobox 2 mutations are associated with variable pituitary phenotype. J Clin Endocrinol Metab 95(2):756-764. doi:10.1210/jc.2009-1334
46. Henderson RH, Williamson KA, Kennedy JS, Webster AR, Holder GE, Robson AG, FitzPatrick DR, van Heyningen V, Moore AT (2009) A rare de novo nonsense mutation in OTX2 causes early onset retinal dystrophy and pituitary dysfunction. Mol vis 15:2442-2447
47. Kelberman D, Rizzoti K, Avilion A, Bitner-Glindzicz M, Cianfarani S, Collins J, Chong WK, Kirk JM, Achermann JC, Ross R, Carmignac D, Lovell-Badge R, Robinson IC, Dattani MT (2006) Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J Clin Investig 116(9):2442-2455. doi:10.1172/JCI28658
48. Hjalt TA, Semina EV, Amendt BA, Murray JC (2000) The Pitx2 protein in mouse development. Dev Dyn 218(1):195-200
49. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, Izpisua-Belmonte JC, Rosenfeld MG (1999) Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 401(6750):279-282. doi:10.1038/45803
50. Charles MA, Suh H, Hjalt TA, Drouin J, Camper SA, Gage PJ (2005) PITX genes are required for cell survival and Lhx3 activation. Mol Endocrinol 19(7):1893-1903. doi:10.1210/me. 2005-0052
51. Gage PJ, Camper SA (1997) Pituitary homeobox 2, a novel member of the bicoid-related family of homeobox genes, is a potential regulator of anterior structure formation. Hum Mol Genet 6(3):457-464
52. Tumer Z, Bach-Holm D (2009) Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations. Eur J Hum Genet 17(12):1527-1539. doi:10.1038/ejhg.2009.93
53. Semina EV, Reiter R, Leysens NJ, Alward WL, Small KW, Datson NA, Siegel-Bartelt J, Bierke-Nelson D, Bitoun P, Zabel BU, Carey JC, Murray JC (1996) Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger Syndrome. Nat Genet 14(4):392-399. doi:10.1038/ng1296-392
54. Sadeghi-Nejad A, Senior B (1974) A familial syndrome of isolated "aplasia" of the anterior pituitary. Diagnostic studies and treatment in the neonatal period. J Pediatr 84(1):79-84
55. Feingold M, Shiere F, Fogels HR, Donaldson D (1969) Rieger's syndrome. Pediatrics 44(4):564-569
56. Mammi I, De Giorgio P, Clementi M, Tenconi R (1998) Cardiovascular anomaly in Rieger Syndrome: heterogeneity or contiguity? Acta Ophthalmol Scand 76(4):509-512
57. Meyer-Marcotty P, Weisschuh N, Dressler P, Hartmann J, Stellzig-Eisenhauer A (2008) Morphology of the sella turcica in Axenfeld-Rieger Syndrome with PITX2 mutation. J oral pathol med 37(8):504-510. doi:10.1111/j.1600-0714.2008.00650.x
58. Reynaud R, Albarel F, Saveanu A, Kaffel N, Castinetti F, Lecomte P, Brauner R, Simonin G, Gaudart J, Carmona E, Enjalbert A, Barlier A, Brue T (2011) Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. Eur J Endocrinol 164(4):457-465. doi:10.1530/EJE-10-0892
59. Laumonnier F, Ronce N, Hamel BC, Thomas P, Lespinasse J, Raynaud M, Paringaux C, Van Bokhoven H, Kalscheuer V, Fryns JP, Chelly J, Moraine C, Briault S (2002) Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 71(6):1450-1455. doi:10.1086/344661
60. Solomon NM, Ross SA, Morgan T, Belsky JL, Hol FA, Karnes PS, Hopwood NJ, Myers SE, Tan AS, Warne GL, Forrest SM, Thomas PQ (2004) Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet 41(9):669-678. doi:10.1136/jmg.2003.016949
61. Woods KS, Cundall M, Turton J, Rizotti K, Mehta A, Palmer R, Wong J, Chong WK, Al-Zyoud M, El-Ali M, Otonkoski T, Martinez-Barbera JP, Thomas PQ, Robinson IC, Lovell-Badge R, Woodward KJ, Dattani MT (2005) Over-and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 76(5):833-849. doi:10. 1086/430134
62. Raetzman LT, Ward R, Camper SA (2002) Lhx4 and Prop1 are required for cell survival and expansion of the pituitary primordia. Development 129(18):4229-4239
63. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA, Westphal H (1997) Multistep control of pituitary organogenesis. Science 278(5344):1809-1812
64. Tajima T, Ishizu K, Nakamura A (2013) Molecular and Clinical Findings in Patients with LHX4 and OTX2 Mutations. Clin Pediatric Endocrinol 22(2):15-23. doi:10.1292/cpe.22.15
65. Castinetti F, Saveanu A, Reynaud R, Quentien MH, Buffin A, Brauner R, Kaffel N, Albarel F, Guedj AM, El Kholy M, Amin M, Enjalbert A, Barlier A, Brue T (2008) A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. J Clin Endocrinol Metab 93(7):2790-2799. doi:10.1210/jc.2007-2389
66. Pfaeffle RW, Hunter CS, Savage JJ, Duran-Prado M, Mullen RD, Neeb ZP, Eiholzer U, Hesse V, Haddad NG, Stobbe HM, Blum WF, Weigel JF, Rhodes SJ (2008) Three novel missense mutations within the LHX4 gene are associated with variable pituitary hormone deficiencies. J Clin Endocrinol Metab 93(3):1062-1071. doi:10.1210/jc.2007-1525
67. Thaler JP, Lee SK, Jurata LW, Gill GN, Pfaff SL (2002) LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions. Cell 110(2):237-249
68. Sharma K, Sheng HZ, Lettieri K, Li H, Karavanov A, Potter S, Westphal H, Pfaff SL (1998) LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons. Cell 95(6):817-828
69. Huang M, Sage C, Li H, Xiang M, Heller S, Chen ZY (2008) Diverse expression patterns of LIM-homeodomain transcription factors (LIM-HDs) in mammalian inner ear development. Dev Dyn 237(11):3305-3312. doi:10.1002/dvdy.21735
70. Hume CR, Bratt DL, Oesterle EC (2007) Expression of LHX3 and SOX2 during mouse inner ear development. Gene Expr Pattern 7(7):798-807. doi:10.1016/j.modgep.2007.05.002
71. Chou SJ, Hermesz E, Hatta T, Feltner D, El-Hodiri HM, Jamrich M, Mahon K (2006) Conserved regulatory elements establish the dynamic expression of Rpx/HesxI in early vertebrate development. Dev biol 292(2):533-545. doi:10.1016/j.ydbio.2005.12.053
72. McGillivray SM, Bailey JS, Ramezani R, Kirkwood BJ, Mellon PL (2005) Mouse GnRH receptor gene expression is mediated by the LHX3 homeodomain protein. Endocrinology 146(5):2180-2185. doi:10.1210/en.2004-1566
73. Granger A, Bleux C, Kottler ML, Rhodes SJ, Counis R, Laverriere JN (2006) The LIM-homeodomain proteins Isl-1 and Lhx3 act with steroidogenic factor 1 to enhance gonadotropespecific activity of the gonadotropin-releasing hormone receptor gene promoter. Mol Endocrinol 20(9):2093-2108. doi:10.1210/me.2005-0184
74. West BE, Parker GE, Savage JJ, Kiratipranon P, Toomey KS, Beach LR, Colvin SC, Sloop KW, Rhodes SJ (2004) Regulation of the follicle-stimulating hormone beta gene by the LHX3 LIM-homeodomain transcription factor. Endocrinology 145(11):4866-4879. doi:10.1210/en.2004-0598
75. Girardin SE, Benjannet S, Barale JC, Chretien M, Seidah NG (1998) The LIM homeobox protein mLIM3/Lhx3 induces expression of the prolactin gene by a Pit-1/GHF-1-independent pathway in corticotroph AtT20 cells. FEBS Lett 431(3):333-338
76. Pfaeffle RW, Savage JJ, Hunter CS, Palme C, Ahlmann M, Kumar P, Bellone J, Schoenau E, Korsch E, Bramswig JH, Stobbe HM, Blum WF, Rhodes SJ (2007) Four novel mutations of the LHX3 gene cause combined pituitary hormone deficiencies with or without limited neck rotation. J Clin Endocrinol Metab 92(5):1909-1919. doi:10.1210/jc.2006-2177
77. Savage JJ, Hunter CS, Clark-Sturm SL, Jacob TM, Pfaeffle RW, Rhodes SJ (2007) Mutations in the LHX3 gene cause dysregulation of pituitary and neural target genes that reflect patient phenotypes. Gene 400(1-2):44-51. doi:10.1016/j.gene.2007.05.017
78. Bhangoo AP, Hunter CS, Savage JJ, Anhalt H, Pavlakis S, Walvoord EC, Ten S, Rhodes SJ (2006) Clinical case seminar: a novel LHX3 mutation presenting as combined pituitary hormonal deficiency. J Clin Endocrinol Metab 91(3):747-753. doi:10.1210/jc.2005-2360
79. Sloop KW, Parker GE, Hanna KR, Wright HA, Rhodes SJ (2001) LHX3 transcription factor mutations associated with combined pituitary hormone deficiency impair the activation of pituitary target genes. Gene 265(1-2):61-69
80. Howard PW, Maurer RA (2001) A point mutation in the LIM domain of Lhx3 reduces activation of the glycoprotein hormone alpha-subunit promoter. J Biol Chem 276(22):19020-19026. doi:10.1074/jbc.M101782200
81. Netchine I, Sobrier ML, Krude H, Schnabel D, Maghnie M, Marcos E, Duriez B, Cacheux V, Moers A, Goossens M, Gruters A, Amselem S (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 25(2):182-186. doi:10.1038/76041
82. Kristrom B, Zdunek AM, Rydh A, Jonsson H, Sehlin P, Escher SA (2009) A novel mutation in the LIM homeobox 3 gene is responsible for combined pituitary hormone deficiency, hearing impairment, and vertebral malformations. J Clin Endocrinol Metab 94(4):1154-1161. doi:10.1210/jc.2008-0325
83. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384(6607):327-333. doi:10.1038/384327a0
84. Yoshida S, Kato T, Susa T, Cai LY, Nakayama M, Kato Y (2009) PROP1 coexists with SOX2 and induces PIT1-commitment cells. Biochem biophys res commun 385(1):11-15. doi:10. 1016/j.bbrc.2009.05.027
85. Ikeshita N, Kawagishi M, Shibahara H, Toda K, Yamashita T, Yamamoto D, Sugiyama Y, Iguchi G, Iida K, Takahashi Y, Kaji H, Chihara K, Okimura Y (2008) Identification and analysis of prophet of Pit-1-binding sites in human Pit-1 gene. Endocrinology 149(11):5491-5499. doi:10.1210/en.2008-0030
86. Kelberman D, Turton JP, Woods KS, Mehta A, Al-Khawari M, Greening J, Swift PG, Otonkoski T, Rhodes SJ, Dattani MT (2009) Molecular analysis of novel PROP1 mutations associated with combined pituitary hormone deficiency (CPHD). Clin Endocrinol 70(1):96-103. doi:10.1111/j.1365-2265.2008.03326.x
87. Zimmermann A, Schenk JP, Grigorescu Sido P, Pfaffle R, Lazea C, Zimmermann T, Heinrich U, Weber MM, Bettendorf M (2007) MRI findings and genotype analysis in patients with childhood onset growth hormone deficiency-correlation with severity of hypopituitarism. J Pediatr Endocrinol Metab 20(5):587-596
88. Vieira TC, da Silva MR, Abucham J (2006) The natural history of the R120C PROP1 mutation reveals a wide phenotypic variability in two untreated adult brothers with combined pituitary hormone deficiency. Endocrine 30(3):365-369
89. Nose O, Tatsumi K, Nakano Y, Amino N (2006) Congenital combined pituitary hormone deficiency attributable to a novel PROP1 mutation (467insT). J Pediatric Endocrinol Metab 19(4):491-498
90. Lemos MC, Gomes L, Bastos M, Leite V, Limbert E, Carvalho D, Bacelar C, Monteiro M, Fonseca F, Agapito A, Castro JJ, Regateiro FJ, Carvalheiro M (2006) PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency. Clin Endocrinol 65(4):479-485. doi:10.1111/j.1365-2265.2006.02617.x
91. Abrao MG, Leite MV, Carvalho LR, Billerbeck AE, Nishi MY, Barbosa AS, Martin RM, Arnhold IJ, Mendonca BB (2006) Combined pituitary hormone deficiency (CPHD) due to a complete PROP1 deletion. Clin Endocrinol 65(3):294-300. doi:10.1111/j.1365-2265.2006.02592.x
92. Reynaud R, Barlier A, Vallette-Kasic S, Saveanu A, Guillet MP, Simonin G, Enjalbert A, Valensi P, Brue T (2005) An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J Clin Endocrinol Metab 90(8):4880-4887. doi:10.1210/jc.2005-0119
93. Lebl J, Vosahlo J, Pfaeffle RW, Stobbe H, Cerna J, Novotna D, Zapletalova J, Kalvachova B, Hana V, Weiss V, Blum WF (2005) Auxological and endocrine phenotype in a populationbased cohort of patients with PROP1 gene defects. Eur J Endocrinol 153(3):389-396. doi:10.1530/eje.1.01989
94. Voutetakis A, Maniati-Christidi M, Kanaka-Gantenbein C, Dracopoulou M, Argyropoulou M, Livadas S, Dacou-Voutetakis C, Sertedaki A (2004) Prolonged jaundice and hypothyroidism as the presenting symptoms in a neonate with a novel Prop1 gene mutation (Q83X). Eur J Endocrinol 150(3):257-264
95. Tatsumi KI, Kikuchi K, Tsumura K, Amino N (2004) A novel PROP1 gene mutation (157delA) in Japanese siblings with combined anterior pituitary hormone deficiency. Clin Endocrinol 61(5):635-640. doi:10.1111/j.1365-2265.2004.02147.x
96. Reynaud R, Chadli-Chaieb M, Vallette-Kasic S, Barlier A, Sarles J, Pellegrini-Bouiller I, Enjalbert A, Chaieb L, Brue T (2004) A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J Clin Endocrinol Metab 89(11):5779-5786. doi:10.1210/jc.2003-032124
97. Bottner A, Keller E, Kratzsch J, Stobbe H, Weigel JF, Keller A, Hirsch W, Kiess W, Blum WF, Pfaffle RW (2004) PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab 89(10):5256-5265. doi:10.1210/jc.2004-0661
98. Paracchini R, Giordano M, Corrias A, Mellone S, Matarazzo P, Bellone J, Momigliano-Richiardi P, Bona G (2003) Two new PROP1 gene mutations responsible for compound pituitary hormone deficiency. Clin Genet 64(2):142-147
99. Arroyo A, Pernasetti F, Vasilyev VV, Amato P, Yen SS, Mellon PL (2002) A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clin Endocrinol 57(2):283-291
100. Vallette-Kasic S, Barlier A, Teinturier C, Diaz A, Manavela M, Berthezene F, Bouchard P, Chaussain JL, Brauner R, Pellegrini-Bouiller I, Jaquet P, Enjalbert A, Brue T (2001) PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 86(9):4529-4535. doi:10.1210/jcem.86.9.7811
101. Pernasetti F, Toledo SP, Vasilyev VV, Hayashida CY, Cogan JD, Ferrari C, Lourenco DM Jr, Mellon PL (2000) Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. J Clin Endocrinol Metab 85(1):390-397. doi:10.1210/jcem.85.1.6324
102. Agarwal G, Bhatia V, Cook S, Thomas PQ (2000) Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. J Clin Endocrinol Metab 85(12):4556-4561. doi:10.1210/jcem.85.12.7013
103. Rosenbloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS (1999) Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 84(1):50-57. doi:10.1210/jcem.84.1.5366
104. Deladoey J, Fluck C, Buyukgebiz A, Kuhlmann BV, Eble A, Hindmarsh PC, Wu W, Mullis PE (1999) "Hot spot" in the PROP1 gene responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 84(5):1645-1650. doi:10.1210/jcem.84.5.5681
105. Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O'Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JA 3rd, Rosenfeld MG (1998) Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 18(2):147-149. doi:10.1038/ng0298-147
106. Fofanova O, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S (1998) Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 83(7):2601-2604. doi:10.1210/jcem.83.7.5094
107. Cogan JD, Wu W, Phillips JA 3rd, Arnhold IJ, Agapito A, Fofanova OV, Osorio MG, Bircan I, Moreno A, Mendonca BB (1998) The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 83(9):3346-3349. doi:10.1210/jcem.83.9.5142
108. Vieira TC, Boldarine VT, Abucham J (2007) Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. Arq Bras Endocrinol Metabol 51(7):1097-1103
109. Halasz Z, Toke J, Patocs A, Bertalan R, Tombol Z, Sallai A, Hosszu E, Muzsnai A, Kovacs L, Solyom J, Fekete G, Racz K (2006) High prevalence of PROP1 gene mutations in Hungarian patients with childhood-onset combined anterior pituitary hormone deficiency. Endocrine 30(3):255-260. doi:10.1007/s12020-006-0002-7
110. Fluck C, Deladoey J, Rutishauser K, Eble A, Marti U, Wu W, Mullis PE (1998) Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg- [ Cys at codon 120 (R120C). J Clin Endocrinol Metab 83(10):3727-3734. doi:10.1210/jcem.83.10.5172
111. Pekic S, Doknic M, Miljic D, Saveanu A, Reynaud R, Barlier A, Brue T, Popovic V (2011) Case seminar: a young female with acute hyponatremia and a sellar mass. Endocrine 40(3):325-331. doi:10.1007/s12020-011-9516-8
112. Lamesch C, Neumann S, Pfaffle R, Kiess W, Paschke R (2002) Adrenocorticotrope deficiency with clinical evidence for late onset in combined pituitary hormone deficiency caused by a homozygous 301-302delAG mutation of the PROP1 gene. Pituitary 5(3):163-168
113. Voutetakis A, Sertedaki A, Livadas S, Xekouki P, Bossis I, Dacou-Voutetakis C, Argyropoulou MI (2006) Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: a persistent pathophysiological mechanism? J Endocrinol Invest 29(5):462-466
114. Voutetakis A, Argyropoulou M, Sertedaki A, Livadas S, Xekouki P, Maniati-Christidi M, Bossis I, Thalassinos N, Patronas N, Dacou-Voutetakis C (2004) Pituitary magnetic resonance imaging in 15 patients with Prop1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J Clin Endocrinol Metab 89(5):2200-2206. doi:10.1210/jc.2003-031765
115. Riepe FG, Partsch CJ, Blankenstein O, Monig H, Pfaffle RW, Sippell WG (2001) Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J Clin Endocrinol Metab 86(9):4353-4357. doi:10.1210/jcem.86.9.7828
116. Fofanova O, Takamura N, Kinoshita E, Vorontsov A, Vladimirova V, Dedov I, Peterkova V, Yamashita S (2000) MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. AJR Am J Roentgenol 174(2):555-559. doi:10.2214/ajr.174.2.1740555
117. Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ (1999) Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. J Clin Endocrinol Metab 84(3):942-945. doi:10.1210/jcem.84.3.5537
118. Himes AD, Raetzman LT (2009) Premature differentiation and aberrant movement of pituitary cells lacking both Hes1 and Prop1. Dev biol 325(1):151-161. doi:10.1016/j.ydbio.2008.10.010
119. Bodner M, Castrillo JL, Theill LE, Deerinck T, Ellisman M, Karin M (1988) The pituitary-specific transcription factor GHF- 1 is a homeobox-containing protein. Cell 55(3):505-518
120. Theill LE, Castrillo JL, Wu D, Karin M (1989) Dissection of functional domains of the pituitary-specific transcription factor GHF-1. Nature 342(6252):945-948. doi:10.1038/342945a0
121. Theill LE, Hattori K, Lazzaro D, Castrillo JL, Karin M (1992) Differential splicing of the GHF1 primary transcript gives rise to two functionally distinct homeodomain proteins. EMBO J 11(6):2261-2269
122. Ingraham HA, Flynn SE, Voss JW, Albert VR, Kapiloff MS, Wilson L, Rosenfeld MG (1990) The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions. Cell 61(6):1021-1033
123. Holloway JM, Szeto DP, Scully KM, Glass CK, Rosenfeld MG (1995) Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain. Genes Dev 9(16):1992-2006
124. Pfaffle RW, Parks JS, Brown MR, Heimann G (1993) Pit-1 and pituitary function. Journal Pediatric Endocrinol 6(3-4):229-233
125. Gordon DF, Woodmansee WW, Black JN, Dowding JM, Bendrick-Peart J, Wood WM, Ridgway EC (2002) Domains of Pit-1 required for transcriptional synergy with GATA-2 on the TSH beta gene. Mol Cell Endocrinol 196(1-2):53-66
126. Kashiwabara Y, Sasaki S, Matsushita A, Nagayama K, Ohba K, Iwaki H, Matsunaga H, Suzuki S, Misawa H, Ishizuka K, Oki Y, Nakamura H (2009) Functions of PIT1 in GATA2-dependent transactivation of the thyrotropin beta promoter. J Mol Endocrinol 42(3):225-237. doi:10.1677/JME-08-0099